| Literature DB >> 30301462 |
Giovanni Balato1, Maria Rizzo2, Tiziana Ascione3, Francesco Smeraglia2, Massimo Mariconda2.
Abstract
BACKGROUND: Knee arthrodesis with intramedullary (IM) nail or external fixator (EF) is the most reliable therapeutic option to achieve definitive infection control in patients with septic failure of total knee arthroplasty (TKA). The first aim of this study was to compare re-infection rates following knee arthrodesis for periprosthetic joint infection (PJI) with IM nail or EF. The second aim was to compare rates of radiographic union, complication, and re-operation as well as clinical outcomes.Entities:
Keywords: External fixator; Intramedullary nail; Knee arthrodesis; Knee arthroplasty; Periprosthetic joint infection; Re-infection
Mesh:
Year: 2018 PMID: 30301462 PMCID: PMC6178263 DOI: 10.1186/s12891-018-2283-4
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Literature search and methodology of selection
Characteristics of the studies included in the systematic review and meta-analysis
| Lead Author, Publication Date | Location | Year of study | Mean | % male | Mean | Participants | Two-stage/ one-stage | Surgical implant | Re-infections/ persisting infections n (%) | Fusion rate % | Major complications | Reoperations | Postoperative limb length discrepancy (mm) | Quality score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intramedullary nail | ||||||||||||||
| Hungerer et al., 2017 [ | Germany | 2003–2012 | 68.6 | 43 | 53 (12–119) | 55 | NS | Short modular nail | 12 (21.8%) | NS | 13 | 20 | 18 | 9/16 |
| Friedrich et al., 2017 [ | Germany | 2008–2014 | 70.2 | NS | 31 (12–74) | 37 | 37/0 | Short modular nail | 5 (13.5%) | NS | 2 | 7 | 22 | 10/16 |
| Hawi et al., 2015 [ | Germany | 2002–2012 | 68.8 | 63 | 67 (24–143) | 27 | 0/27 | Short modular cemented nail | 4 (14.8%) | NS | 0 | 3 | NS | 11/16 |
| Röhner et al., 2015 [ | Germany | 1997–2013 | 68 | 31 | 71 (12–204) | 26 | 26/0 | Short modular cemented nail | 13 (50%) | NS | 0 | 13 | NS | 10/16 |
| Miralles-Muñoz et al., 2014 [ | Spain | 2001–2010 | 74.6 | 14 | 50 (36–60) | 29 | 29/0 | Short modular cemented nail | 2 (6.9%) | NS | 4 | 3 | 8 | 12/16 |
| Scarponi et al., 2014 [ | Italy | 2000–2011 | 65 | 47 | 62 (24–105) | 38 | 38/0 | Short modular cementless nail | 4 (10.5%) | NS | 5 | 5 | 13 | 9/16 |
| Iacono et al., 2013 [ | Italy | 2004–2009 | 69.3 | NS | 34(13–72) | 21 | 21/0 | Short modular cementless nail | 3 (14.3%) | NS | 0 | 3 | 8 | 9/16 |
| Putman et al., 2013 [ | France | 2005–2008 | 67 | NS | 50 (28–90) | 31 | 25/6 | Short modular cementless nail | 6 (19.4%) | 68 (NS) | 10 | 3 | 10 | 10/16 |
| Barton et al., 2008 [ | UK | 1993–2004 | NS | NS | 53 | 10 | 9/1 | Short modular nail | 1 (10%) | 100 (8) | 2 | 2 | NS | 8/16 |
| Talmo et al., 2007 [ | USA | NS | 67 | 41 | 48 (13–114) | 29 | 25/4 | Long modular cementless nail | 4 (13.8%) | 83 (6) | 2 | 5 | 30 | 11/16 |
| Bargiotas et al., 2006 [ | USA | 1999–2003 | 68 | 42 | 49 (18–72) | 12 | 12/0 | Long locked cementless nail | 2 (16.6%) | 83 (5.5) | 2 | 2 | 55 | 10/16 |
| Crockarell and Mihalko, 2005 [ | USA | 1991–2000 | 70.5 | 40 | 68 (24–96) | 10 | 9/1 | Long locked cementless nail | 1 (10%) | 100 (NS) | NS | NS | 37 | 9/16 |
| Domingo et al., 2004 [ | Spain | 1990–2001 | 67.8 | 50 | Minimum 1 year | 10 | 10/0 | Short locked cementless nail | 1 (10%) | 90 (5) | 2 | 1 | NS | 8/16 |
| Volpi et al., 2004 [ | France | 1997–2001 | 68.6 | 43 | 19 | 12 | 12/0 | Short modular cementless nail | 2 (16.6%) | 100 (3.6) | 1 | 1 | NS | 7/16 |
| Gore and Gassner, 2003 [ | USA | 1977–2001 | 71.5 | 56 | 54 (12–288) | 16 | 14/2 | Long Kuntscher or modular nail | 2 (12.5%)) | 87.5 (NS) | 3 | 4 | NS | 8/16 |
| Waldman et al., 1999 [ | USA | NS | 64 | 38 | 29 (24–90) | 21 | 21/0 | Short modular cementless nail | 0 (0%) | 95 (6.3) | 2 | 2 | NS | 8/16 |
| Lai et al., 1998 [ | Taiwan | 1988–1994 | 68.2 | 43 | 47 (18–94) | 28 | 8/20 | Short locked cementless nail | 1 (3.6%) | 93 (5.2) | 2 | 1 | 25 | 9/16 |
| Wilde and Stearns, 1989 [ | USA | 1983–1988 | 65 | 33 | Minimum 24 | 10 | 10/0 | Long Kuntscher nail | 3 (30%) | 60 (6.6) | 6 | 6 | 36 | 8/16 |
| External fixator | ||||||||||||||
| Balci, 2016 [ | Turkey | 1999–2012 | 67 | 18 | 51 | 17 | 17/0 | Unilateral EF | 1 (6%) | 94 (7.6) | 4 | 6 | 29 | 11/16 |
| Corona et al., 2013 [ | Spain | 2004–2009 | 81 | 48 | 50 (12–81) | 21 | 0/21 | Unilateral EF | 3 (14%) | 81 (10.3) | NS | NS | 47 | 9/16 |
| Iacono et al., 2013 [ | Italy | 2001–2004 | 68.5 | NS | 93(82–110) | 10 | 10/0 | Semi circular Hoffmann EF | 0 (0%) | 90 (6.7) | 1 | 2 | 45 | 9/16 |
| Reddy et al., 2011 [ | India | 2003–2010 | 62.2 | 63 | 46 (12–84) | 16 | 3/16 | Ilizarov frame | 1 (6%) | 94 (6.6) | 6 | 6 | 44 | 9/16 |
| Parratten et al., 2007 [ | France | 1990–2003 | 64.8 | 43 | 88 (12–162) | 14 | 6/8 | 2 unilateral EF | 0 (0%) | 93 (7.3) | 2 | 2 | 45 | 9/16 |
| Klinger et al., 2006 [ | Germany | 1990–2002 | 66.2 | 61 | 56 (24–132) | 18 | 11/7 | Unilateral EF | 1 (6%) | 83 (6.3) | 3 | 2 | 36 | 9/16 |
| Domingo et al., 2004 [ | Spain | 1990–2001 | 69.1 | 45 | Minimum 1 year | 11 | 11/0 | Unilateral EF (3) | 0 (0%) | 100 (6.7) | 1 | 0 | NS | 8/16 |
| Biplanar EF (8) | 100 (6.1) | |||||||||||||
| David et al., 2001 [ | Israel | 1988- | 65.9 | 39 | 41 (18–60) | 10 | NS | Ilizarov frame | 0 (0%) | 100 (6.4) | 1 | 0 | 37 | 8/16 |
| Hak et al., 1995 [ | USA | 1973–1990 | 58.5 | 45 | 43 (12–186) | 20 | NS | Unilateral EF (7) | 1 (5%) | 57 (7.1) | 13 | 4 | NS | 8/16 |
| Biplanar EF (13) | 62 (7.1) | |||||||||||||
| De Cloedt et al., 1994 [ | Belgium | 1984–1992 | 67.7 | 40 | 68 (14–108) | 15 | NS | 2 unilateral EF | 8 (53%) | 67 (7.3) | NS | 8 | NS | 8/16 |
NS Not stated, EF External fixator
Fig. 2Rates of re-infection in patients treated by knee arthrodesis with intramedullary nail (1 outlier removed [12]). The summary estimates presented were calculated using random-effects models; CI, confidence interval (bars)
Fig. 3Rates of re-infection in patients treated by knee arthrodesis with external fixator (1 outlier removed [21]). The summary estimates presented were calculated using random-effects models; CI, confidence interval (bars)
Subgroup analysis of intramedullary nail arthrodesis studies
| Outcome | Publications | Cases | Long nail | Short nail |
|
|---|---|---|---|---|---|
| Re-infection | 18 | Total | 77 | 345 | |
| No | 65 | 291 | 0.998 | ||
| Yes | 12 | 54 | |||
| Bone fusion | 11 | Total | 77 | 112 | |
| No | 13 | 14 | 0.397 | ||
| Yes | 64 | 98 | |||
| Time to fusion (months ± SD) | 8 | 5.62 ± 1.6 | 6.03 ± 0.6 | 0.626 |
SD Standard deviation
Subgroup analysis of external fixator arthrodesis studies
| Outcome | Publications | Unilateral | Bipl/Circ | p | Pins | Wires |
| |
|---|---|---|---|---|---|---|---|---|
| Re-infection | 10 | No | 61 | 76 | 0.410 | 105a | 25 | 0.745 |
| Yes | 5 | 10 | 6a | 1 | ||||
| Bone fusion | 10 | No | 11 | 13 | 0.795 | 23 | 1 | 0.066 |
| Yes | 55 | 73 | 103 | 25 | ||||
| Time to fusion (months ± SD) | 10 | 7.60 ± 1.6 | 6.77 ± 0.5 | 0.314 | 7.38 ± 1.3 | 6.45 ± 0.2 | 0.086 |
Bipl/Circ Biplanar/Circular, SD Standard deviation
a1 outlier study removed
Clinical Outcomes
| Intramedullary nail | External Fixator | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Studies ( | Patients ( | Mean | SD | Studies ( | Patients ( | Mean | SD | |||
| SF-36 or SF-12 questionnaire | PCS | 3 | 94 | 35.0 | 8.7 | 2 | 38 | 41.1 | 2.5 | 0.357 |
| MCS | 3 | 94 | 48.3 | 4.7 | 2 | 38 | 49.0 | 14.6 | 0.941 | |
| PF | 3 | 63 | 25.5 | 15.3 | 1 | 18 | 32.1 | |||
| BP | 3 | 63 | 43.8 | 17.8 | 1 | 18 | 47.4 | |||
| RP | 3 | 63 | 31.6 | 15.3 | 1 | 18 | 30.8 | |||
| GH | 3 | 63 | 45.9 | 10.3 | 1 | 18 | 46.9 | |||
| SF | 3 | 63 | 56.1 | 12.6 | 1 | 18 | 56.4 | |||
| RE | 3 | 63 | 45.4 | 24.7 | 1 | 18 | 46.7 | |||
| VT | 3 | 63 | 43.6 | 9.8 | 1 | 18 | 43.1 | |||
| MH | 3 | 63 | 63.5 | 11.8 | 1 | 18 | 58.3 | |||
| VAS pain | 7 | 180 | 2.5 | 1.7 | 3 | 49 | 2.9 | 0.8 | 0.627 | |
| LLD (mm) | 11 | 300 | 23.8 | 14.8 | 7 | 108 | 40.4 | 6.6 | 0.005 | |
SD Standard deviation, SF-36 Short form-36, SF-12 Short form-12, PCS Physical component summary, MCS Mental component summary, PF Physical functioning, BP Bodily pain, RP Role-physical, GH General health, SF Social functioning, RE Role-emotional, VT Vitality, MH Mental health, VAS Visual analogue scale, LLD Limb length discrepancy